Removing anonymity protection and utilization review decisions: a real-world case under a single-payer health system

被引:0
|
作者
Wang, Chih-Kuang [1 ]
Chien, Shih-Jung [2 ]
Lee, Po-Chang [3 ]
Cheng, Shou-Hsia [4 ,5 ]
机构
[1] Natl Hlth Insurance Adm, Dept Planning, Taipei, Taiwan
[2] Natl Hlth Insurance Adm, Dept Med Affairs, Taipei, Taiwan
[3] Natl Hlth Insurance Adm, Taipei, Taiwan
[4] Natl Taiwan Univ, Inst Hlth Policy & Management, 17 Xu Zhou Rd,Room 618, Taipei 10055, Taiwan
[5] Natl Taiwan Univ, Populat Hlth Res Ctr, Taipei, Taiwan
关键词
QUALITY-OF-CARE; RELIABILITY; ASSESSMENTS;
D O I
10.1038/s41598-022-16536-1
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The effects of anonymity on utilization review has never been examined in the real world. This study aimed to evaluate the impact of removing anonymity protection for claims reviewers on their review decisions. Using a single-blinded repeated measures design, we randomly selected 1457 claims cases (with 12,237 orders) that had been anonymously reviewed and reimbursed in 2016 and had them re-reviewed in a signed review program in 2017 under the Taiwanese National Health Insurance scheme. The signed review policy significantly decreased the likelihood of a deduction decision at the case and the order level (P < 0.001). Furthermore, signed reviewers tended to make more "too lenient" decisions, and were less likely to make "too harsh" decisions. Removing anonymity protection dramatically reduced the deduction rate and overturned the tendency of decisions from "too harsh" to "too lenient". However, whether to maintain the anonymity of utilization reviews is a challenge for health authorities around the globe.
引用
收藏
页数:8
相关论文
共 39 条
  • [31] Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South Korea
    Novick, Diego
    Cho, Jae Min
    Colman, Sam
    Szende, Agota
    [J]. DRUGS-REAL WORLD OUTCOMES, 2022, 9 (02) : 263 - 274
  • [32] Preliminary Real-World Evidence Supporting the Efficacy of a Remote Neurofeedback System in Improving Mental Health: Retrospective Single-Group Pretest-Posttest Study
    Whitehead, Jocelyne C.
    Neeman, Ron
    Doniger, Glen M.
    [J]. JMIR FORMATIVE RESEARCH, 2022, 6 (07)
  • [33] Real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in Brazil: a retrospective, single-center study
    Pajecki, Denis
    Kawamoto, Flavio
    Batista Dantas, Anna Carolina
    Andrade, Priscila Caldeira
    Brasil, Nissia Capello
    Junqueira, Silvio Mauro
    Pirozelli de Oliveira, Fernanda Maria
    Ribeiro, Rodrigo Antonini
    Santo, Marco Aurelio
    [J]. CLINICS, 2020, 75
  • [34] Addressing misalignments to improve the US health care system by integrating patient-centred care, patient-centred real-world data, and knowledge-sharing: a review and approaches to system alignment
    Douglas S. Levine
    Douglas A. Drossman
    [J]. Discover Health Systems, 1 (1):
  • [35] Methods of evaluating the safety and effectiveness of cardiac ablation catheters using real-world data: A test-case of the national evaluation system for health technology coordinating center (NESTCC)
    Zhang, Shumin
    Dhruva, Sanket
    Chen, Jiajing
    Yu, Yue
    Cafri, Guy
    Noseworthy, Peter A.
    Doshi, Amit
    Jiang, Guoqian
    Agboola, Kolade M.
    Herrin, Jeph
    Farr, Kimberly Collison
    Zhou, Meijia
    Brandt, Eric
    Forsyth, Thomas
    Ervin, Keondae
    Ross, Joseph
    Drozda, Joseph, Jr.
    Coplan, Paul
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 436 - 436
  • [36] Treatment Patterns and Outcomes of 1205 Patients on Novel Agents in the US Veterans Health Administration System: Results From the Largest Retrospective EMR and Chart Review Study in the Real-World Setting
    Awan, Farrukh T.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 4 - 6
  • [37] Treatment Patterns and Outcomes of 1205 Patients on Novel Agents in the US Veterans Health Administration (VHA) System: Results from the Largest Retrospective EMR and Chart Review Study in the Real-World Setting
    Frei, Christopher R.
    Le, Hannah
    McHugh, Daniel
    Elesinmogun, Cynthia
    Galley, Samantha
    Franklin, Kathleen
    Tavera, Juan
    Martinez, Michelle Janania
    Gregorio, David J.
    Ananth, Snegha
    Uribe, Ricardo
    Surapaneni, Prathibha
    Espinoza-Gutarra, Manuel Ricardo
    Song, Michael
    Jones, Xavier
    Teng, Chengwen
    Obodozie-Ofoegbu, Obiageri O.
    Nooruddin, Zohra
    [J]. BLOOD, 2019, 134
  • [38] IMPACT OF DE NOVO REAL-WORLD EVIDENCE (RWE) GENERATION IN HEALTH TECHNOLOGY ASSESSMENT (HTA): CASE STUDY OF THE INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW'S (ICER) SICKLE CELL DISEASE (SCD) ASSESSMENT
    Jaksa, A.
    Bradt, P.
    Patrick, A.
    Schneeweiss, S.
    Spackman, E.
    [J]. VALUE IN HEALTH, 2020, 23 : S708 - S708
  • [39] Real-world treatment patterns and outcomes in chronic lymphocytic leukemia (CLL) patients on novel agents in the US Veterans Health Administration (VHA) system: preliminary analysis of a retrospective electronic medical record (EMR) and chart review study
    Nooruddin, Zohra
    Le, Hannah
    McHugh, Daniel
    Elesinmogun, Cynthia
    Galley, Samantha
    Franklin, Kathleen
    Tavera, Juan
    Gregorio, David
    Ananth, Snegha
    Uribe, Ricardo
    Surapaneni, Prathibha
    Espinoza-Gutarra, Manuel
    Song, Michael
    Jones, Xavier
    Frei, Christopher
    [J]. LEUKEMIA & LYMPHOMA, 2020, 61 : 61 - 63